|
1
|
Benjamin T and Thota PN: Synchronous or
metachronous occurrence of lesions of different histologic types in
patients with esophageal cancer. Clin Gastroenterol Hepatol.
15:780–781. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lu HB: MicroRNA-556-3p promotes the
progression of esophageal cancer via targeting DAB2IP. Eur Rev Med
Pharmacol Sci. 22:6816–6823. 2018.PubMed/NCBI
|
|
3
|
Cheng Z, Geng H, Cheng Y, Dong N, Ning F,
Yu Z, Jian J and Chen S: Effects of MiR-210 on proliferation,
apoptosis and invasion abilities of esophageal cancer cells. J
BUON. 23:814–819. 2018.PubMed/NCBI
|
|
4
|
Lin Y, Totsuka Y, Shan B, Wang C, Wei W,
Qiao Y, Kikuchi S, Inoue M, Tanaka H and He Y: Esophageal cancer in
high-risk areas of China: Research progress and challenges. Ann
Epidemiol. 27:215–221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo LW, Huang HY, Shi JF, Lv LH, Bai YN,
Mao AY, Liao XZ, Liu GX, Ren JS, Sun XJ, et al: Medical expenditure
for esophageal cancer in China: A 10-year multicenter retrospective
survey (2002–2011). Chin J Cancer. 36:732017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schizas D, Lidoriki I and Liakakos T: Can
we rely on body mass index when predicting postoperative outcomes
and survival of esophageal cancer patients? J BUON.
23:1572018.PubMed/NCBI
|
|
7
|
Wang Y, Zhu L, Xia W and Wang F: Anatomy
of lymphatic drainage of the esophagus and lymph node metastasis of
thoracic esophageal cancer. Cancer Manag Res. 10:6295–6303. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma JL, Zhao Y, Guo CY, Hu HT, Zheng L,
Zhao EJ and Li HL: Dietary vitamin B intake and the risk of
esophageal cancer: A meta-analysis. Cancer Manag Res. 10:5395–5410.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang X, Zhou X, Hu Q, Sun B, Deng M, Qi X
and Lu M: Advances in esophageal cancer: A new perspective on
pathogenesis associated with long non-coding RNAs. Cancer Lett.
413:94–101. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fanelli GN, Gasparini P, Coati I, Cui R,
Pakula H, Chowdhury B, Valeri N, Loupakis F, Kupcinskas J,
Cappellesso R and Fassan M: LONG-NONCODING RNAs in gastroesophageal
cancers. Noncoding RNA Res. 3:195–212. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng Q, Zhang H, Yao D, Chen WD and Wang
YD: Emerging role of Non-Coding RNAs in esophageal squamous cell
carcinoma. Int J Mol Sci. 21:2582019. View Article : Google Scholar
|
|
12
|
Abraham JM and Meltzer SJ: Long Noncoding
RNAs in the pathogenesis of barrett's esophagus and esophageal
carcinoma. Gastroenterology. 153:27–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen WJ, Zhang F, Zhao X and Xu J: lncRNAs
and esophageal squamous cell carcinoma-implications for
pathogenesis and drug development. J Cancer. 7:1258–1264. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin CY and Xu HM: Novel perspectives of
long non-coding RNAs in esophageal carcinoma. Carcinogenesis.
36:1255–1262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang Z, Wei G, Zhang L and Xu Z: Signature
microRNAs and long noncoding RNAs in laryngeal cancer recurrence
identified using a competing endogenous RNA network. Mol Med Rep.
19:4806–4818. 2019.PubMed/NCBI
|
|
17
|
Gao J, Yin X, Yu X, Dai C and Zhou F: Long
noncoding RNA LINC00488 functions as a ceRNA to regulate
hepatocellular carcinoma cell growth and angiogenesis through
miR-330-5. Dig Liver Dis. 51:1050–1059. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu H, Wang S, Zhou S, Meng Q, Ma X, Song
X, Wang L and Jiang W: Drug resistance-related competing
interactions of lncRNA and mRNA across 19 cancer types. Mol Ther
Nucleic Acids. 16:442–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han DL, Wang LL, Zhang GF, Yang WF, Chai
J, Lin HM, Fu Z and Yu JM: miRNA-485-5p, inhibits esophageal cancer
cells proliferation and invasion by down-regulating O-linked
N-acetylglucosamine transferase. Eur Rev Med Pharmacol Sci.
23:2809–2816. 2019.PubMed/NCBI
|
|
20
|
Gao F, Wu H, Wang R, Guo Y, Zhang Z, Wang
T, Zhang G, Liu C and Liu J: MicroRNA-485-5p suppresses the
proliferation, migration and invasion of small cell lung cancer
cells by targeting flotillin-2. Bioengineered. 10:1–12. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nishimura Y, Nagata K, Katano S, Hirota S,
Nakamura K, Higuchi F, Soejima T and Sai H; Japanese Society for
Esophageal Diseases, : Severe complications in advanced esophageal
cancer treated with radiotherapy after intubation of esophageal
stents: A questionnaire survey of the Japanese Society for
Esophageal Diseases. Int J Radiat Oncol Biol Phys. 56:1327–1332.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
